{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:14:56Z","timestamp":1771269296562,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Complex molecular events lead to development and progression of liver cirrhosis to HCC. Differentially expressed nuclear membrane associated proteins are responsible for the functional and structural alteration during the progression from cirrhosis to carcinoma. Although alterations\/ post translational modifications in protein expression have been extensively quantified, complementary analysis of nuclear membrane proteome changes have been limited. Deciphering the molecular mechanism that differentiate between normal and disease state may lead to identification of biomarkers for carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Many proteins displayed differential expression when nuclear membrane proteome of hepatocellular carcinoma (HCC), fibrotic liver, and HepG2 cell line were assessed using 2-DE and ESI-Q-TOF MS\/MS. From the down regulated set in HCC, we have identified for the first time a 15 KDa cytochrome b5A (CYB5A), ATP synthase subunit delta (ATPD) and Hemoglobin subunit beta (HBB) with 11, 5 and 22 peptide matches respectively. Furthermore, nitrosylation studies with S-nitrosocysteine followed by immunoblotting with anti SNO-cysteine demonstrated a novel and biologically relevant post translational modification of thiols of CYB5A in HCC specimens only. Immunofluorescence images demonstrated increased protein S-nitrosylation signals in the tumor cells and fibrotic region of HCC tissues. The two other nuclear membrane proteins which were only found to be nitrosylated in case of HCC were up regulated ATP synthase subunit beta (ATPB) and down regulated HBB. The decrease in expression of CYB5A in HCC suggests their possible role in disease progression. Further insight of the functional association of the identified proteins was obtained through KEGG\/ REACTOME pathway analysis databases. String 8.3 interaction network shows strong interactions with proteins at high confidence score, which is helpful in characterization of functional abnormalities that may be a causative factor of liver pathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These findings may have broader implications for understanding the mechanism of development of carcinoma. However, large scale studies will be required for further verification of their critical role in development and progression of HCC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1559-0275-10-6","type":"journal-article","created":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T08:15:27Z","timestamp":1370074527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinoma"],"prefix":"10.1186","volume":"10","author":[{"given":"Rizma","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadia","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jui Yvonne","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jameson","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-Bashar Abdul","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atta M","family":"Nawabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abid","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Ataur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhat","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"key":"37_CR1","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet. 2003, 362: 1907-1917. 10.1016\/S0140-6736(03)14964-1","journal-title":"Lancet"},{"key":"37_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0168-8278(00)80428-6","volume":"32","author":"K Okuda","year":"2000","unstructured":"Okuda K: Hepatocellular carcinoma. J Hepatol. 2000, 32: 225-237.","journal-title":"J Hepatol"},{"key":"37_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJM199903113401001","volume":"340","author":"HB El-Serag","year":"1999","unstructured":"El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999, 340: 745-750. 10.1056\/NEJM199903113401001","journal-title":"N Engl J Med"},{"key":"37_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00004836-199410000-00011","volume":"19","author":"AM Di Bisceglie","year":"1994","unstructured":"Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH: Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol. 1994, 19: 222-226. 10.1097\/00004836-199410000-00011","journal-title":"J Clin Gastroenterol"},{"key":"37_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1055\/s-0032-1304843","volume":"137","author":"JU Marquardt","year":"2012","unstructured":"Marquardt JU, Galle PR, Teufel A: Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy. Dtsch Med Wochenschr. 2012, 137: 855-860.","journal-title":"Dtsch Med Wochenschr"},{"key":"37_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4297\/najms.2011.3167","volume":"3","author":"M el Tazi","year":"2011","unstructured":"el Tazi M, Essadi I, M'rabti H, Touyar A, Errihani PH: Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. N Am J Med Sci. 2011, 3: 167-175.","journal-title":"N Am J Med Sci"},{"key":"37_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jmv.10293","volume":"69","author":"U Dumpis","year":"2003","unstructured":"Dumpis U, Kovalova Z, Jansons J, Cupane L, Sominskaya I, Michailova M, Karayiannis P, Gardovska D, Viazov S, Ross S, Roggendorf M, Pumpens P: An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol. 2003, 69: 331-338. 10.1002\/jmv.10293","journal-title":"J Med Virol"},{"key":"37_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/1615-9861(200110)1:10<1249::AID-PROT1249>3.0.CO;2-1","volume":"1","author":"TK Seow","year":"2001","unstructured":"Seow TK, Liang RC, Leow CK, Chung MC: Hepatocellular carcinoma: from bedside to proteomics. Proteomics. 2001, 1: 1249-1263. 10.1002\/1615-9861(200110)1:10<1249::AID-PROT1249>3.0.CO;2-1","journal-title":"Proteomics"},{"key":"37_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1023\/A:1024038132381","volume":"7","author":"BK Shin","year":"2002","unstructured":"Shin BK, Hong W, Hanash S: Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer. J Mammary Gland Biol Neoplasia. 2002, 7: 407-413. 10.1023\/A:1024038132381","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"37_CR10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1478-3231.2012.02792.x","volume":"32","author":"P Song","year":"2012","unstructured":"Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W: The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int. 2012, 32: 1053-1063. 10.1111\/j.1478-3231.2012.02792.x","journal-title":"Liver Int"},{"key":"37_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1155\/2001\/963023","volume":"17","author":"LF Steel","year":"2001","unstructured":"Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, London WT, Block T: A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers. 2001, 17: 179-189. 10.1155\/2001\/963023","journal-title":"Dis Markers"},{"key":"37_CR12","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1053\/j.gastro.2006.02.015","volume":"130","author":"T Berg","year":"2006","unstructured":"Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S: Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology. 2006, 130: 1086-1097. 10.1053\/j.gastro.2006.02.015","journal-title":"Gastroenterology"},{"key":"37_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1074\/mcp.M100015-MCP200","volume":"1","author":"G Zhou","year":"2002","unstructured":"Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF, Zhao Y: 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics. 2002, 1: 117-124. 10.1074\/mcp.M100015-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"37_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1155\/2011\/310675","volume":"31","author":"B M\u00ednguez","year":"2011","unstructured":"M\u00ednguez B, Lachenmayer A: Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Marker. 2011, 31: 181-190. 10.1155\/2011\/310675. 10.1155\/2011\/310675","journal-title":"Dis Marker"},{"key":"37_CR15","first-page":"35","volume":"28","author":"DW Chan","year":"2005","unstructured":"Chan DW, Colantonio DA: Clinical proteomics:cancer diagnostics?. J Clin Ligand Assay. 2005, 28: 35-37.","journal-title":"J Clin Ligand Assay"},{"key":"37_CR16","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1158\/1055-9965.EPI-05-0774","volume":"14","author":"Z Zhang","year":"2005","unstructured":"Zhang Z, Chan DW: Cancer proteomics:in pursuit of \u201ctrue\u201d biomarker discovery. (Editorial). cancer epidemiol. Biomark Prevent. 2005, 14: 2283-2286. 10.1158\/1055-9965.EPI-05-0774. 10.1158\/1055-9965.EPI-05-0774","journal-title":"Biomark Prevent"},{"key":"37_CR17","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1002\/pmic.200500893","volume":"6","author":"Y Song","year":"2006","unstructured":"Song Y, Hao Y, Sun A, Li T, Li W, Guo L, Yan Y, Geng C, Chen N, Zhong F, Wei H, Jiang Y, He F: Sample preparation project for the subcellular proteome of mouse liver. Proteomics. 2006, 6: 5269-5277. 10.1002\/pmic.200500893","journal-title":"Proteomics"},{"key":"37_CR18","doi-asserted-by":"publisher","first-page":"e21849","DOI":"10.1371\/journal.pone.0021849","volume":"6","author":"TY Lee","year":"2011","unstructured":"Lee TY, Chen YJ, Lu TC, Huang HD, Chen YJ: SNOSite: exploiting maximal dependence decomposition to identify cysteine S-nitrosylation with substrate site specificity. PLoSOne. 2011, 6: e21849-","journal-title":"PLoSOne"},{"key":"37_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI774","volume":"101","author":"PL Majano","year":"1998","unstructured":"Majano PL, Garc\u00eda-Monz\u00f3n C, L\u00f3pez-Cabrera M, Lara-Pezzi E, Fern\u00e1ndez-Ruiz E, Garc\u00eda-Iglesias C, Borque MJ, Moreno-Otero R: Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest. 1998, 101: 1343-1352. 10.1172\/JCI774","journal-title":"J Clin Invest"},{"key":"37_CR20","first-page":"1325","volume":"7","author":"MA Rahman","year":"2001","unstructured":"Rahman MA, Dhar DK, Yamaguchi E, Maruyama S, Sato T, Hayashi H, Ono T, Yamanoi A, Kohno H, Nagasue N: Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus- positive cases. Clin Cancer Res. 2001, 7: 1325-1332.","journal-title":"Clin Cancer Res"},{"key":"37_CR21","doi-asserted-by":"publisher","first-page":"12770","DOI":"10.1073\/pnas.220416097","volume":"97","author":"SP Hussain","year":"2000","unstructured":"Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC: Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci USA. 2000, 97: 12770-12775. 10.1073\/pnas.220416097","journal-title":"Proc Natl Acad Sci USA"},{"key":"37_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan C: Nitric oxide and the immune response. Nat Immunol. 2001, 2: 907-916.","journal-title":"Nat Immunol"},{"key":"37_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1164\/rccm.200510-1584PP","volume":"173","author":"B Gaston","year":"2006","unstructured":"Gaston B, Singel D, Doctor A, Stamler JS: S -nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med. 2006, 173: 1186-1193. 10.1164\/rccm.200510-1584PP","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.molmed.2009.06.007","volume":"15","author":"MW Foster","year":"2009","unstructured":"Foster MW, Hess DT, Stamler JS: Protein S - nitrosylation in health and disease: a current perspective. Trends Mol Med. 2009, 15: 391-404. 10.1016\/j.molmed.2009.06.007","journal-title":"Trends Mol Med"},{"issue":"19","key":"37_CR25","doi-asserted-by":"publisher","first-page":"19ra13","DOI":"10.1126\/scitranslmed.3000328","volume":"2","author":"W Wei","year":"2010","unstructured":"Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L: S -nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med. 2010, 2 (19): 19ra13- 10.1126\/scitranslmed.3000328","journal-title":"Sci Transl Med"},{"key":"37_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrm1569","volume":"6","author":"DT Hess","year":"2005","unstructured":"Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005, 6: 150-166. 10.1038\/nrm1569","journal-title":"Nat Rev Mol Cell Biol"},{"key":"37_CR27","first-page":"3037","volume":"62","author":"L Liu","year":"2002","unstructured":"Liu L, Xu-Welliver M, Kanugula S, Pegg AE: Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res. 2002, 62: 3037-3043.","journal-title":"Cancer Res"},{"key":"37_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrc1910","volume":"6","author":"D Fukumura","year":"2006","unstructured":"Fukumura D, Kashiwagi S, Jain RK: The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006, 6: 521-534. 10.1038\/nrc1910","journal-title":"Nat Rev Cancer"},{"key":"37_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1083\/jcb.148.5.899","volume":"148","author":"E Pedrazzini","year":"2000","unstructured":"Pedrazzini E, Villa A, Longhi R, Bulbarelli A, Borgese N: Mechanism of residence of cytochrome b(5), a tail-anchored protein, in the endoplasmic reticulum. J Cell Biol. 2000, 148: 899-914. 10.1083\/jcb.148.5.899","journal-title":"J Cell Biol"},{"key":"37_CR30","doi-asserted-by":"publisher","first-page":"13265","DOI":"10.1074\/jbc.M414673200","volume":"280","author":"AV Pandey","year":"2005","unstructured":"Pandey AV, Miller WL: Regulation of 17, 20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem. 2005, 280: 13265-13271. 10.1074\/jbc.M414673200","journal-title":"J Biol Chem"},{"key":"37_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1124\/dmd.108.024810","volume":"37","author":"RA Stringer","year":"2009","unstructured":"Stringer RA, Strain-Damerell C, Nicklin P, Houston JB: Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos. 2009, 37: 1025-1034. 10.1124\/dmd.108.024810","journal-title":"Drug Metab Dispos"},{"key":"37_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0163-7258(02)00327-3","volume":"97","author":"JB Schenkman","year":"2003","unstructured":"Schenkman JB, Jansson I: The many roles of cytochrome b5. Pharmacol Ther. 2003, 97: 139-152. 10.1016\/S0163-7258(02)00327-3","journal-title":"Pharmacol Ther"},{"key":"37_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jbt.10052","volume":"16","author":"TD Porter","year":"2002","unstructured":"Porter TD: The roles of cytochrome b5 in cytochrome P450 reactions. J Biochem Mol Toxicol. 2002, 16: 311-316. 10.1002\/jbt.10052","journal-title":"J Biochem Mol Toxicol"},{"key":"37_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/prep.2001.1578","volume":"24","author":"H Yamazaki","year":"2002","unstructured":"Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T: Roles of nadph-p450 reductase and apo- and holo-cytochrome b5 on xenobiotics oxidations catalyzed by 12 recombinant human cytochrome p450s expressed in membranes of Escherichia coli. Protein Expr Purif. 2002, 24: 329-337. 10.1006\/prep.2001.1578","journal-title":"Protein Expr Purif"},{"key":"37_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ: The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011, 32: 81-151. 10.1210\/er.2010-0013","journal-title":"Endocr Rev"},{"key":"37_CR36","doi-asserted-by":"publisher","first-page":"e1000598","DOI":"10.1371\/journal.pbio.1000598","volume":"9","author":"M Blanc","year":"2011","unstructured":"Blanc M, Hsieh WY, Robertson KA, Watterson S, Shui G, Lacaze P, Khondoker M, Dickinson P, Sing G, Rodr\u00c3guez-Mart\u00c3n S, Phelan P, Forster T, Strobl B, Muller M, Riemersma R, Osborne T, Wenk MR, Angulo A, Ghazal P: Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol. 2011, 9: e1000598- 10.1371\/journal.pbio.1000598","journal-title":"PLoS Biol"},{"key":"37_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11248-010-9426-1","volume":"20","author":"RD Finn","year":"2011","unstructured":"Finn RD, McLaughlin LA, Hughes C, Song C, Henderson CJ, RolandWolf C: Cytochrome b null mouse: a new model for studying inherited skin disorders and the role of unsaturated fattyacids in normal homeostasis. Transgenic Res. 2011, 20: 491-502. 10.1007\/s11248-010-9426-1","journal-title":"Transgenic Res"},{"key":"37_CR38","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/oxfordjournals.jbchem.a135224","volume":"97","author":"K Abe","year":"1985","unstructured":"Abe K, Kimura S, Kizawa R, Anan FK, Sugita Y: Amino acid sequences of cytochrome b5 from human, porcine, and bovine erythrocytes and comparison with liver microsomal cytochrome b5. J Biochem. 1985, 97: 1659-1668.","journal-title":"J Biochem"},{"key":"37_CR39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.jbchem.a124347","volume":"115","author":"H Takematsu","year":"1994","unstructured":"Takematsu H, Kawano T, Koyama S, Kozutsumi Y, Suzuki A, Kawasaki T: Reaction mechanism underlying CMP-N-acetylneuraminic acid hydroxylation in mouse liver: formation of a ternary complex of cytochrome b5, CMP-N-acetylneuraminic acid, and a hydroxylation enzyme. J Biochem. 1994, 115: 381-386.","journal-title":"J Biochem"},{"key":"37_CR40","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1073\/pnas.71.6.2539","volume":"71","author":"B Guiard","year":"1974","unstructured":"Guiard B, Groudinsky O, Lederer F: Homology between bakers\u2019 yeast cytochrome b2 and liver microsomal cytochrome b5. Proc Natl Acad Sci USA. 1974, 71: 2539-2543. 10.1073\/pnas.71.6.2539","journal-title":"Proc Natl Acad Sci USA"},{"key":"37_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1432-1033.1977.tb11379.x","volume":"74","author":"B Guiard","year":"1977","unstructured":"Guiard B, Lederer F: The \u201cb5-like\u201d domain from chicken- liver sulfite oxidase: a new case of common ancestral origin with liver cytochrome b5 and bakers\u2019 yeast cytochrome b5 core. Eur J Biochem. 1977, 74: 181-190. 10.1111\/j.1432-1033.1977.tb11379.x","journal-title":"Eur J Biochem"},{"key":"37_CR42","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1134\/S0006297908100052","volume":"73","author":"AV Yantsevich","year":"2008","unstructured":"Yantsevich AV, Gilep AA, Usanov SA: Mechanism of electron transfer in fusion protein cytochrome b5\u2013NADH_cytochrome b5 reductase. Biochemistry (Mosc). 2008, 73: 1096-1107. 10.1134\/S0006297908100052. 10.1134\/S0006297908100052","journal-title":"Biochemistry (Mosc)"},{"key":"37_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B","volume":"14","author":"TM Dunn","year":"1998","unstructured":"Dunn TM, Haak D, Monaghan E, Beeler TJ: Synthesis of monohydroxylated inositolphosphorylceramide (IPC-C) in Saccharomyces cerevisiae requires Scs7p, a protein with both a cytochrome b5-like domain and a hydroxylase\/desaturase domain. Yeast. 1998, 14: 311-321. 10.1002\/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B","journal-title":"Yeast"},{"key":"37_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5306\/wjco.v3.i2.15","volume":"3","author":"PY Wai","year":"2012","unstructured":"Wai PY, Kuo PC: Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm. World J Clin Oncol. 2012, 3: 15-23. 10.5306\/wjco.v3.i2.15","journal-title":"World J Clin Oncol"},{"key":"37_CR45","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/(SICI)1522-2683(20000401)21:6<1202::AID-ELPS1202>3.0.CO;2-I","volume":"21","author":"SM Hanash","year":"2000","unstructured":"Hanash SM: Biomedical applications of two dimensional electrophoresis using immobilized pH gradients: Current status. Electrophoresis. 2000, 21: 1202-1209. 10.1002\/(SICI)1522-2683(20000401)21:6<1202::AID-ELPS1202>3.0.CO;2-I","journal-title":"Electrophoresis"},{"key":"37_CR46","first-page":"842","volume":"18","author":"MA Reymond","year":"1997","unstructured":"Reymond MA, Sanchez JC, Hughes GJ, G\u00fcnther K, Riese J, Tortola S, Peinado MA, Kirchner T, Hohenberger W, Hochstrasser DF, K\u00f6ckerling F: Standardized characterization of gene expression in human colorectal epithelium by two dimensional electrophoresis. Electrophoresis. 1997, 18: 842-848.","journal-title":"Electrophoresis"},{"key":"37_CR47","first-page":"7778","volume":"254","author":"SR Keyes","year":"1979","unstructured":"Keyes SR, Alfano JA, Jansson I, Cinti DL: Rat liver microsomal elongation of fattyacids. J Biochem. 1979, 254: 7778-7784.","journal-title":"J Biochem"},{"key":"37_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1124\/dmd.108.023424","volume":"37","author":"L Gan","year":"2009","unstructured":"Gan L, von Moltke LL, Trepanier LA, Harmatz JS, Greenblatt DJ, Court MH: Role of NADPH-cytochrome P450 reductase and cytochrome-b5\/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes. Drug Metab Dispos. 2009, 37: 90-96. 10.1124\/dmd.108.023424","journal-title":"Drug Metab Dispos"},{"key":"37_CR49","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1517\/17425255.4.9.1181","volume":"4","author":"DF Lewis","year":"2008","unstructured":"Lewis DF, Ito Y: Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions. Expert Opin Drug Metab Toxicol. 2008, 4: 1181-1186. 10.1517\/17425255.4.9.1181","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"37_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/elps.1150080203","volume":"8","author":"H Blum","year":"1987","unstructured":"Blum H, Beier H, Gross HJ: Silver staining of proteins in polyacrylamide gels. Electrophoresis. 1987, 8: 93-99. 10.1002\/elps.1150080203. 10.1002\/elps.1150080203","journal-title":"Electrophoresis"},{"key":"37_CR51","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/ac950914h","volume":"68","author":"A Shevchenko","year":"1996","unstructured":"Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996, 68: 850-858. 10.1021\/ac950914h","journal-title":"Anal Chem"},{"key":"37_CR52","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/elps.201000015","volume":"31","author":"AR Asif","year":"2010","unstructured":"Asif AR, Oellerich M, Amstrong VW, Gross U, Reichard U: Analysis of the cellular Aspergillusfumigatus proteome that reacts with sera from rabbits developing an acquired immunity after experimental aspergillosis. Electrophoresis. 2010, 31: 1947-1958. 10.1002\/elps.201000015","journal-title":"Electrophoresis"},{"key":"37_CR53","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/nar\/gki475","volume":"33","author":"B Zhang","year":"2005","unstructured":"Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33: 741-748. 10.1093\/nar\/gki475. 10.1093\/nar\/gki475","journal-title":"Nucleic Acids Res"},{"key":"37_CR54","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/nar\/gkn760","volume":"37","author":"LJ Jensen","year":"2009","unstructured":"Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C: STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009, 37: 412-416. 10.1093\/nar\/gkn760. 10.1093\/nar\/gkn760","journal-title":"Nucleic Acids Res"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1559-0275-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:25:19Z","timestamp":1630542319000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/1559-0275-10-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1186\/1559-0275-10-6","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]},"assertion":[{"value":"17 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}